Investing.com - Amarin reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Amarin announced earnings per share of $0.03 on revenue of $142.2M. Analysts polled by Investing.com anticipated EPS of $-0.0488 on revenue of $148.1M.
Amarin shares are up 27% from the beginning of the year and are trading at $5.19 , down-from-52-week-high.They are outperforming the S&P 500 which is up 11.37% from the start of the year.
Amarin follows other major Healthcare sector earnings this month
Amarin's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar